142 related articles for article (PubMed ID: 10906100)
1. Expression of VLA-2, VLA-3, and alpha(v) integrin receptors in uveal melanoma: association with microvascular architecture of the tumour and prognostic value.
Anastassiou G; Schilling H; Djakovic S; Bornfeld N
Br J Ophthalmol; 2000 Aug; 84(8):899-902. PubMed ID: 10906100
[TBL] [Abstract][Full Text] [Related]
2. Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours.
Schadendorf D; Gawlik C; Haney U; Ostmeier H; Suter L; Czarnetzki BM
J Pathol; 1993 Aug; 170(4):429-34. PubMed ID: 8105045
[TBL] [Abstract][Full Text] [Related]
3. A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins.
Elshaw SR; Sisley K; Cross N; Murray AK; MacNeil SM; Wagner M; Nichols CE; Rennie IG
Br J Ophthalmol; 2001 Jun; 85(6):732-8. PubMed ID: 11371496
[TBL] [Abstract][Full Text] [Related]
4. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
[TBL] [Abstract][Full Text] [Related]
5. Integrin expression in uveal melanoma differs from cutaneous melanoma.
ten Berge PJ; Danen EH; van Muijen GN; Jager MJ; Ruiter DJ
Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3635-40. PubMed ID: 8258522
[TBL] [Abstract][Full Text] [Related]
6. Microvascular loops and networks in uveal melanoma.
Kivelä T; Mäkitie T; Al-Jamal RT; Toivonen P
Can J Ophthalmol; 2004 Jun; 39(4):409-21. PubMed ID: 15327107
[TBL] [Abstract][Full Text] [Related]
7. Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth.
Boyd SR; Tan DS; de Souza L; Neale MH; Myatt NE; Alexander RA; Robb M; Hungerford JL; Cree IA
Br J Ophthalmol; 2002 Apr; 86(4):440-7. PubMed ID: 11914215
[TBL] [Abstract][Full Text] [Related]
8. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.
Shah AA; Bourne TD; Murali R
Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity for integrin expression and cytokine-mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins.
Mortarini R; Anichini A; Parmiani G
Int J Cancer; 1991 Feb; 47(4):551-9. PubMed ID: 1995484
[TBL] [Abstract][Full Text] [Related]
10. Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels.
Schadendorf D; Heidel J; Gawlik C; Suter L; Czarnetzki BM
J Natl Cancer Inst; 1995 Mar; 87(5):366-71. PubMed ID: 7531774
[TBL] [Abstract][Full Text] [Related]
11. Novel mouse model for primary uveal melanoma: a pilot study.
Süsskind D; Hurst J; Rohrbach JM; Schnichels S
Clin Exp Ophthalmol; 2017 Mar; 45(2):192-200. PubMed ID: 27505446
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.
Coupland SE; Anastassiou G; Stang A; Schilling H; Anagnostopoulos I; Bornfeld N; Stein H
J Pathol; 2000 Jun; 191(2):120-6. PubMed ID: 10861569
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.
Coupland SE; Bechrakis N; Schüler A; Anagnostopoulos I; Hummel M; Bornfeld N; Stein H
Br J Ophthalmol; 1998 Aug; 82(8):961-70. PubMed ID: 9828785
[TBL] [Abstract][Full Text] [Related]
14. Molecular role(s) for integrins in human melanoma invasion.
Seftor RE; Seftor EA; Hendrix MJ
Cancer Metastasis Rev; 1999; 18(3):359-75. PubMed ID: 10721490
[TBL] [Abstract][Full Text] [Related]
15. p53 Immunoreactivity, Ki-67 expression, and microcirculation patterns in melanoma of the iris, ciliary body, and choroid.
Chowers I; Folberg R; Livni N; Pe'er J
Curr Eye Res; 2002 Feb; 24(2):105-8. PubMed ID: 12187481
[TBL] [Abstract][Full Text] [Related]
16. Temporal expression of VLA-2 and modulation of its ligand specificity by rat glomerular epithelial cells in vitro.
Mendrick DL; Kelly DM
Lab Invest; 1993 Dec; 69(6):690-702. PubMed ID: 8264232
[TBL] [Abstract][Full Text] [Related]
17. Expression of Fas and Fas ligand in uveal melanoma: biological implication and prognostic value.
Anastassiou G; Coupland SE; Stang A; Boeloeni R; Schilling H; Bornfeld N
J Pathol; 2001 Aug; 194(4):466-72. PubMed ID: 11523055
[TBL] [Abstract][Full Text] [Related]
18. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
[TBL] [Abstract][Full Text] [Related]
19. Nestin expression in primary and metastatic uveal melanoma - possible biomarker for high-risk uveal melanoma.
Djirackor L; Shakir D; Kalirai H; Petrovski G; Coupland SE
Acta Ophthalmol; 2018 Aug; 96(5):503-509. PubMed ID: 29338117
[TBL] [Abstract][Full Text] [Related]
20. Expression of functional very late antigen-alpha 1, -alpha 2, -alpha 3 and -alpha 6 integrins on Ewing's sarcoma and primitive peripheral neuroectodermal tumour cells and modulation by interferon-gamma and tumour necrosis factor-alpha.
van Valen F; Hanenberg H; Jürgens H
Eur J Cancer; 1994; 30A(14):2119-25. PubMed ID: 7857712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
